DiaMedica Therapeutics Inc. (DMAC) stock
DMACNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$8.38+0.05 (+0.60%)
Close on Nov 17, 2026Market cap $451.90MP/E –Yield –
DiaMedica Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
DiaMedica Therapeutics's price to sales ratio was 79.2× on Apr 30, 2019.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2019 | Apr 30, 2019 | 79.2× | – |
See a number that looks wrong?